2022Nottingham, England, September 29, 2014 -- /EPR NETWORK/ -- Effect of Pulsed Electromagnetic Field Therapyon Prostate Volume and Vascularity in the Treatment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Mode Authors: Raffaella Leoci, 1* Giulio Aiudi,1 Fabio Silvestre, 1 Elaine Lissner, 2 and Giovanni Michele Lacalandra 1 - Department of Emergency and Organ Transplantation (DETO), Section of Veterinary Clinic and Animal Production, University of Bari Aldo Moro, Valenzano, Bari,Italy 2, Parsemus Foundation, Berkeley, California.
BACKGROUND.
Benign prostatic hyperplasia (BPH) is a result of urogenital aging. Recent studies suggest that an age-related impairment of the blood supply to the lower urinary tract plays a role in the development of BPH and thus may be a contributing factor in the pathogenesis of BPH. The canine prostate is a model for understanding abnormal growth of the human prostate gland. We studied the efficacy of pulsed electromagnetic field therapy (PEMF) in dogs to modify prostate blood flow and evaluated its effect on BPH.
METHODS.
PEMF (5min, twice a day for 3 weeks) was performed on 20 dogs affected by BPH. Prostatic volume, Doppler assessment by ultrasonography, libido, semen quality, testosterone levels, and seminal plasma volume, composition and pH were evaluated before and after treatment.
RESULTS.
The 3 weeks of PEMF produced a significant reduction in prostatic volume (average 57%) without any interference with semen quality, testosterone levels or libido. Doppler parameters showed a reduction of peripheral resistances and a progressive reduction throughout the trial of the systolic peak velocity, end-diastolic velocity, mean velocity, mean, and peak gradient of the blood flow in the dorsal branch of the prostatic artery. The pulsatility index and the resistance index did not vary significantly over time.
CONCLUSIONS.
The efficacy of PEMF on BPH in dogs, with no side effects, suggests the suitability of this treatment in humans and supports the hypothesis that impairment of blood supply to the lower urinary tract may be a causative factor in the development of BPH.
Prostate 74:1132–1141, 2014.
To read full study click here ( http://onlinelibrary.wiley.com/doi/10.1002/pros.22829/full )
MAGCELL® VETRI immediately soothes inflammation, improves cellular metabolism, and increases mobility. High-dose pulse magnetic fields are generated using an innovative process. They serve as the transfer media for electrical treatment fields. The fields are physiologically effective in the joint area and threshold values for important cellular regeneration and differentiation processes are exceeded.
MAGCELL® for Humans
High-dose pulse magnetic fields are generated using an innovative process. The fields act as the transfer medium for electrical treatment fields. They are physiologically effective even at a tissue depth of up to 3-4 cm. MAGCELL® offers new possible applications through very short treatment times and simple, mobile treatment.
MAGCELL® ARTHRO
Long-term relief of arthrosis pain through electrode-free electrotherapy
MAGCELL® MICROCIRC
Increase circulation in the long term through electrode-free electrotherapy
About PhysioPod UK:
PhysioPod UK Limited are the exclusive suppliers in the UK and Ireland for MAGCELL® and the range of products from Physiomed Elektromedizin AG. http://www.physiopod.co.uk.
Contact:
Mary Fickling
PhysioPod UK Limited
Sherbrook Road
Daybrook, Nottingham, NG5 6AS
01159 167 685
info@physiopod.co.uk
http://www.physiopod.co.uk
